{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:52:17Z","timestamp":1791888737951,"version":"4.3.4"},"reference-count":44,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Neuro-oncology Research Fund","id":[{"id":"https:\/\/ror.org\/05ghs6f64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100030827","name":"NHS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>We report the long-term survival and the causes of excess mortality in a cohort of pituitary adenoma (PA) patients treated with radiotherapy, with or without prior surgery at up to 50 years of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate long-term survival and causes of excess mortality in patients with PAs treated with radiotherapy, with or without prior surgery, and to examine the relationship between treatment factors, particularly radiotherapy dose and mortality outcomes over extended follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>426 patients treated with radiotherapy at the Royal Marsden Hospital during 1962 and 1994 with or without prior surgery were followed up via the NHS Central Register to identify deaths and emigrations. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated by comparing observed deaths with expected rates based on national age, sex, year, and period-specific mortality rates for England and Wales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>260 deaths were recorded compared to 144 expected (SMR 1.8; AER 140.7). The main contributors to excess mortality were cerebrovascular disease (SMR 4.9; AER 61.4), endocrine\/metabolic disease (SMR 5.6), and mental and behavioral disorders (SMR 5.0). Both all-cause and cerebrovascular-specific mortality were associated with increasing radiotherapy dose and with the use of surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with PAs treated with surgery and radiotherapy have an increased mortality compared to the general population, with the principal contributor cerebrovascular accident mortality. The observed dose-response suggests a potential relationship between radiotherapy and vascular morbidity. The findings highlight the need for long-term surveillance and proactive management of vascular risk factors and in patients requiring radiotherapy and avoiding excessive radiotherapy doses. Whether modern high-precision fractionated radiotherapy techniques reduce the risk of cerebrovascular morbidity and mortality requires long-term studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag115","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:01:44Z","timestamp":1778760104000},"source":"Crossref","is-referenced-by-count":0,"title":["Excess mortality in radiotherapy-treated pituitary adenoma patients: 50-year follow-up"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9015-9843","authenticated-orcid":false,"given":"Anna","family":"Fitzgerald","sequence":"first","affiliation":[{"name":"UCD School of Medicine, University College Dublin , Dublin D04 W6W8 ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-7926","authenticated-orcid":false,"given":"James","family":"de Boisanger","sequence":"additional","affiliation":[{"name":"Neuro-oncology Unit, The Royal Marsden Hospital NHS Foundation Trust , London SW3 6JJ ,","place":["UK"]},{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Cooke","sequence":"additional","affiliation":[{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Traish","sequence":"additional","affiliation":[{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5550-4159","authenticated-orcid":false,"given":"Anthony","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-4815","authenticated-orcid":false,"given":"Nicola","family":"Rosenfelder","sequence":"additional","affiliation":[{"name":"Neuro-oncology Unit, The Royal Marsden Hospital NHS Foundation Trust , London SW3 6JJ ,","place":["UK"]},{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Solda","sequence":"additional","affiliation":[{"name":"Neuro-oncology Unit, The Royal Marsden Hospital NHS Foundation Trust , London SW3 6JJ ,","place":["UK"]},{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brada","sequence":"additional","affiliation":[{"name":"The Institute of Cancer Research , London SW7 3RP ,","place":["UK"]},{"name":"Department of Molecular and Clinical Cancer Medicine, University of Liverpool , Liverpool L69 7BE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"5","key":"2026101306314278700_bvag115-B1","first-page":"319","article-title":"Pituitary adenomas: an overview","volume":"88","author":"Lake","year":"2013","journal-title":"Am Fam Physician"},{"issue":"4","key":"2026101306314278700_bvag115-B2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nec.2019.05.001","article-title":"Molecular biology of pituitary adenomas","volume":"30","author":"Faltermeier","year":"2019","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"2026101306314278700_bvag115-B3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J Neurooncol"},{"key":"2026101306314278700_bvag115-B4","first-page":"1","volume-title":"DeGroot's Endocrinology: Basic Science and Clinical Practice","author":"Rosenfelder","year":"2023","edition":"8th ed."},{"key":"2026101306314278700_bvag115-B5","volume-title":"Endotext","author":"Feingold","year":"2000"},{"issue":"2","key":"2026101306314278700_bvag115-B6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3857\/roj.2016.01683","article-title":"Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma","volume":"34","author":"Kim","year":"2016","journal-title":"Radiat Oncol J"},{"issue":"1","key":"2026101306314278700_bvag115-B7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-020-01084-6","article-title":"Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study","volume":"24","author":"Oh","year":"2021","journal-title":"Pituitary"},{"issue":"1","key":"2026101306314278700_bvag115-B8","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1038\/s41598-021-94658-8","article-title":"Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004-2016","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"2026101306314278700_bvag115-B9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2265.2006.02545.x","article-title":"Hypopituitarism and mortality in pituitary adenoma","volume":"65","author":"Lindholm","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026101306314278700_bvag115-B10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11102-016-0764-8","article-title":"Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study","volume":"20","author":"Olsson","year":"2017","journal-title":"Pituitary"},{"issue":"7","key":"2026101306314278700_bvag115-B11","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1210\/jc.2015-1475","article-title":"Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish nationwide study","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026101306314278700_bvag115-B12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/cen.13141","article-title":"ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres","volume":"85","author":"O'Reilly","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9254","key":"2026101306314278700_bvag115-B13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"2026101306314278700_bvag115-B14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0360-3016(91)90677-V","article-title":"Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy","volume":"21","author":"McCollough","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2026101306314278700_bvag115-B15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0360-3016(00)00503-4","article-title":"The efficacy of conventional radiation therapy in the management of pituitary adenoma","volume":"47","author":"Sasaki","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2026101306314278700_bvag115-B16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026101306314278700_bvag115-B17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","article-title":"Cerebrovascular mortality in patients with pituitary adenoma","volume":"57","author":"Brada","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026101306314278700_bvag115-B18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"4","key":"2026101306314278700_bvag115-B19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ijrobp.2007.11.057","article-title":"Long-term outcomes of radiotherapy for pituitary adenomas","volume":"71","author":"Snead","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2026101306314278700_bvag115-B20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026101306314278700_bvag115-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-017-2530-9","article-title":"Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review","volume":"135","author":"van Westrhenen","year":"2017","journal-title":"J Neurooncol"},{"issue":"3","key":"2026101306314278700_bvag115-B22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2014-3697","article-title":"Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of growth hormone treatment in adults","volume":"100","author":"van Varsseveld","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026101306314278700_bvag115-B23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cancers9080103","article-title":"Secondary intracranial tumors following radiotherapy for pituitary adenomas: a systematic review","volume":"9","author":"Yamanaka","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2026101306314278700_bvag115-B24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jc.2016-3402","article-title":"Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary\/sellar lesions","volume":"102","author":"Burman","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026101306314278700_bvag115-B25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2213-8587(22)00160-7","article-title":"Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance","volume":"10","author":"Hamblin","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026101306314278700_bvag115-B26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12020-024-04073-y","article-title":"Comparative mortality in pituitary adenomas subtypes: a tertiary referral center study","volume":"87","author":"Toma","year":"2025","journal-title":"Endocrine"},{"issue":"23","key":"2026101306314278700_bvag115-B27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"2026101306314278700_bvag115-B28","first-page":"381","article-title":"Oestrogens and the heart","volume":"54","author":"Rosano","year":"1999","journal-title":"Therapie"},{"issue":"8","key":"2026101306314278700_bvag115-B29","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jnnp.2007.138925","article-title":"Late neurocognitive sequelae in patients with WHO grade I meningioma","volume":"80","author":"Dijkstra","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2026101306314278700_bvag115-B30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1227\/NEU.0b013e318212badb","article-title":"Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas","volume":"69","author":"Waagemans","year":"2011","journal-title":"Neurosurgery"},{"key":"2026101306314278700_bvag115-B31","doi-asserted-by":"crossref","first-page":"1064216","DOI":"10.3389\/fendo.2022.1064216","article-title":"Pituitary adenomas and cerebrovascular disease: a review on pathophysiology, prevalence, and treatment","volume":"13","author":"Osorio","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2026101306314278700_bvag115-B32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026101306314278700_bvag115-B33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"issue":"4","key":"2026101306314278700_bvag115-B34","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing's syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026101306314278700_bvag115-B35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3803\/EnM.2015.30.4.443","article-title":"Diagnosis and treatment of hypopituitarism","volume":"30","author":"Kim","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"2026101306314278700_bvag115-B36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2042018816687240","article-title":"Current best practice in the management of patients after pituitary surgery","volume":"8","author":"Prete","year":"2017","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"2026101306314278700_bvag115-B37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2026101306314278700_bvag115-B38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.radonc.2009.09.011","article-title":"Radiotherapy for pituitary adenomas: long-term efficacy and toxicity","volume":"93","author":"Erridge","year":"2009","journal-title":"Radiother Oncol"},{"issue":"10046","key":"2026101306314278700_bvag115-B39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet"},{"issue":"9497","key":"2026101306314278700_bvag115-B40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"2026101306314278700_bvag115-B41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijrobp.2022.06.079","article-title":"Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a PENTEC normal tissue outcomes comprehensive review","volume":"119","author":"Waxer","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2026101306314278700_bvag115-B42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11764-023-01350-z","article-title":"Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis","volume":"18","author":"Ib\u00e1\u00f1ez-Juli\u00e1","year":"2024","journal-title":"J Cancer Surviv"},{"issue":"2","key":"2026101306314278700_bvag115-B43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11060-015-1839-5","article-title":"Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors","volume":"124","author":"Aizer","year":"2015","journal-title":"J Neurooncol"},{"issue":"4","key":"2026101306314278700_bvag115-B44","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag115\/68288694\/bvag115.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/11\/bvag115\/68288694\/bvag115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/11\/bvag115\/68288694\/bvag115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:31:53Z","timestamp":1791887513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag115\/8678442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag115","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,5,14]]},"article-number":"bvag115"}}